Use cautionMedical device recall · FDA · Published May 22, 2025
Change Healthcare Cardiology Software Update May Cause Unexpected Shutdowns
Change Healthcare recalls cardiology hemodynamics software version 15.0.1 due to unexpected shutdowns. Affected users should stop using the software immediately.
“Change Healthcare Cardiology Software Update May Cause Unexpected Shutdowns.” GovInfoNow, updated August 18, 2026. https://govinfonow.com/recall/52229-change-healthcare-cardiology-software-update-may-cause-unexpected-shutdowns. Based on FDA recall #Z-2072-2025 (https://api.fda.gov/device/enforcement.json?search=recall_number:%22Z-2072-2025%22&limit=1).
Change Healthcare Canada Company voluntarily recalled Change Healthcare Cardiology Hemodynamics Software on May 22, 2025, according to the FDA. The software may unexpectedly shut down due to a software update issue.
The recall was issued because a software update may cause the software to unexpectedly shut down, according to complaints received by the company.
Context
GovInfoNow's records show Change Healthcare Canada Company has had eight other recalls since February 10, 2020. Other recent recalls of similar products include GE Medical Systems Portrait Compute V1.2 Software Recall (July 20, 2026) and GE HealthCare APEXPRO v5.0 Software Risk (April 24, 2026).
How to tell if you have this one
Check if you have the software version 15.0.1 with UDI: (01)17540262100129. The software is used by healthcare providers for cardiology hemodynamics monitoring.
FDA lists each product line separately under one recall event. Check your product description, lot or code numbers against each row. Every row shares the hazard and remedy on this page.
Classification
Class II
Status
Ongoing
Distribution
Worldwide - US Nationwide distribution in the states of AL, AR, CA, FL, KY MO, MS, NE, NH, NJ, PA, TN, TX, WA and the countries of Australia, Canada, Germany, Great Britain, Ireland, Israel, New Zealand.
Immediately stop using the affected software version 15.0.1/UDI: (01)17540262100129 to prevent unexpected shutdowns.
Where it went and when
Where it was distributed
Distributed nationwide and abroad; the notice names 14 states.
Named in the notice
Covered by “nationwide”
Not listed
FDA distribution: “Worldwide - US Nationwide distribution in the states of AL, AR, CA, FL, KY MO, MS, NE, NH, NJ, PA, TN, TX, WA and the countries of Australia, Canada, Germany, Great Britain, Ireland, Israel, New Zealand.” States read from FDA’s own wording; “not listed” means the notice does not name it.
Named in the notice: Alabama, Arkansas, California, Florida, Kentucky, Mississippi, Missouri, Nebraska, New Hampshire, New Jersey, Pennsylvania, Tennessee, Texas, Washington.
Recall timeline
FDA published this recall 48 days after the firm started it.
1Firm started the recall
2FDA classified it Class II
3Published in FDA’s Enforcement Report
Dates from the agency record only; steps without a date are left out.
The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.
Official source: FDA Recall #Z-2072-2025 (May 22, 2025) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for Z-2072-2025 to see it in context.
Plain-language summary written by qwen3:4b on August 18, 2026, from the official record above. Not reviewed by a person — if it conflicts with the FDA notice, the notice is correct. Report an error on this page.
GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.